Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Zhonghua Yi Xue Za Zhi ; 96(23): 1838-42, 2016 Jun 21.
Artículo en Chino | MEDLINE | ID: mdl-27356794

RESUMEN

OBJECTIVE: To compare the therapeutic effect of portal vein stenting and endovascular implantation of iodine-125 seeds strand followed by transcatheter arterial chemoembolization combined with or without sorafenib in patients for hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (MPVTT). METHODS: A total of 53 patients with HCC complicated by MPVTT who received portal vein stenting and endovascular implantation of iodine-125 seeds strand followed by transcatheter arterial chemoembolization combined without (group A, n=38) or with (group B, n=15) sorafenib in Affiliated Yancheng Hospital of Southeast University Medical College during January 2010 and August 2015 were analyzed retropectively.Overal survival, progress free survival and procedure-related adverse event were compared between the two groups. RESULTS: The technical success rate was 100% for placement of (125)I seeds strand and stent in the obstructed main portal vein.No serious procedure-related adverse events occurred. Median survival time of group A and B were 12.1 and 14.8 months, respectively (P=0.037). Additionally, Median progress free survival time of group A and B were 2.8 and 4.0 months, respectively (P=0.002). CONCLUSIONS: Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined with sorafenib could improve the survival time, the progress free survival time of patients with HCC complicated by MPVTT.


Asunto(s)
Carcinoma Hepatocelular/terapia , Quimioembolización Terapéutica/métodos , Radioisótopos de Yodo/uso terapéutico , Neoplasias Hepáticas/terapia , Vena Porta/cirugía , Stents , Arterias , Carcinoma Hepatocelular/complicaciones , Terapia Combinada , Procedimientos Endovasculares , Humanos , Radioisótopos de Yodo/administración & dosificación , Niacinamida/administración & dosificación , Niacinamida/análogos & derivados , Niacinamida/uso terapéutico , Compuestos de Fenilurea/administración & dosificación , Compuestos de Fenilurea/uso terapéutico , Vena Porta/fisiopatología , Sorafenib , Trombosis , Resultado del Tratamiento
2.
J Neurochem ; 76(1): 173-81, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11145990

RESUMEN

Converging lines of evidence implicate the beta-amyloid peptide (Ass) as causative in Alzheimer's disease. We describe a novel class of compounds that reduce A beta production by functionally inhibiting gamma-secretase, the activity responsible for the carboxy-terminal cleavage required for A beta production. These molecules are active in both 293 HEK cells and neuronal cultures, and exert their effect upon A beta production without affecting protein secretion, most notably in the secreted forms of the amyloid precursor protein (APP). Oral administration of one of these compounds, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, to mice transgenic for human APP(V717F) reduces brain levels of Ass in a dose-dependent manner within 3 h. These studies represent the first demonstration of a reduction of brain A beta in vivo. Development of such novel functional gamma-secretase inhibitors will enable a clinical examination of the A beta hypothesis that Ass peptide drives the neuropathology observed in Alzheimer's disease.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Encéfalo/metabolismo , Dipéptidos/administración & dosificación , Endopeptidasas/metabolismo , Administración Oral , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/genética , Secretasas de la Proteína Precursora del Amiloide , Precursor de Proteína beta-Amiloide/genética , Precursor de Proteína beta-Amiloide/metabolismo , Animales , Ácido Aspártico Endopeptidasas , Encéfalo/citología , Encéfalo/efectos de los fármacos , Células Cultivadas , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Endopeptidasas/efectos de los fármacos , Inhibidores Enzimáticos/administración & dosificación , Femenino , Humanos , Inyecciones Subcutáneas , Riñón/citología , Riñón/efectos de los fármacos , Riñón/metabolismo , Masculino , Ratones , Ratones Transgénicos , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Fragmentos de Péptidos/metabolismo
3.
Zhongguo Zhong Yao Za Zhi ; 25(8): 458-61, 2000 Aug.
Artículo en Chino | MEDLINE | ID: mdl-12515205

RESUMEN

OBJECTIVE: To gain a clear idea on the resources of medicinal plant Hypericum in Guizhou. METHOD: Conducting field investigation and consulting related specimens and data. RESULT: The distribution, growing environment and medicinal parts of 18 species of Hypericun have been clarified, and a key for their identification is given. CONCLUSION: A scientific basis for further study of the medicinal plant Hypericum in Guizhou Province has been provided.


Asunto(s)
Hypericum/anatomía & histología , Plantas Medicinales/anatomía & histología , Antivirales , China , Conservación de los Recursos Naturales , Medicamentos Herbarios Chinos , Hypericum/clasificación , Plantas Medicinales/clasificación
4.
Zhongguo Yao Li Xue Bao ; 16(4): 337-40, 1995 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7668105

RESUMEN

AIM: To study immuno-antitumor action mechanism of RGP-b. RGP-b (Rehmannia glutinosa polysaccaride b) is a new component isolated from the herb, had an average molecular mass of 160 kDa and 5 kinds of monosaccharides as acid-splitting products. Its HPLC showed a main sharp peak at 162 kDa. METHODS: The kinetic effects of RGP-b on IL-2 secretion, cytotoxic T-lymphocyte (CTL) activities and L3T4+, lyt-2+ T-lymphocyte subset in mice bearing S180 were observed. RESULTS: RGP-b 10 or 20 mg kg-1 ip obviously attenuated the decrease of CTL cytotoxity caused by excessive tumor growth on d 9 after the administration, but only partly ameliorated the descent of IL-2. Its effect on lyt-2+ subset was quite parallel with that on CTL cytotoxity. RGP-b kept the ratio of L3T4+ to lyt-2+ subset lower than that of control. CONCLUSION: Improving the production of lyt-2+ CTL and its cytotoxity were an essential immuno-antitumor mechanisms of RGP-b.


Asunto(s)
Medicamentos Herbarios Chinos/química , Polisacáridos/farmacología , Sarcoma 180/inmunología , Subgrupos de Linfocitos T/inmunología , Animales , Relación CD4-CD8 , Citotoxicidad Inmunológica/efectos de los fármacos , Femenino , Interleucina-2/metabolismo , Ratones , Polisacáridos/aislamiento & purificación
5.
Zhongguo Zhong Yao Za Zhi ; 17(12): 715-7, 762, 1992 Dec.
Artículo en Chino | MEDLINE | ID: mdl-1304750

RESUMEN

The germinant rate of Bupleurum falcatum can be raised by soaking the seeds in BA or GA3 solution. The effect of BA is better than that of GA3. BA and GA3 cannot be used together, otherwise the effect on germination will be decreased or checked. BA or GA3 should be used before the natural sowing time, for after this time they will be useless or even harmful.


Asunto(s)
Giberelinas/farmacología , Reguladores del Crecimiento de las Plantas/farmacología , Plantas Medicinales/crecimiento & desarrollo , Semillas/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA